Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study

European Respiratory Journal

Volumn 39, Issue 1, 2012, Pages 38-45

  Jenkins, C R ^a   Celli, B ^b   Anderson, J A ^e   Ferguson, G T ^c   Jones, P W ^f   Vestbo, J ^g,i   Yates, J C ^d   Calverley, P M A ^h  

^a WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Institute of Southeast Michigan   (United States)

^d GLAXOSMITHKLINE   (United States)

^e GLAXOSMITHKLINE   (United Kingdom)

^f ST GEORGE S HOSPITAL   (United Kingdom)

^g WYTHENSHAWE HOSPITAL   (United Kingdom)

^h UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

ⁱ HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Chronic obstructive pulmonary disease; Exacerbations; Mortality; Seasonal patterns; Torch survival study

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; PLACEBO; SALMETEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INHALER; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; MORTALITY; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; RISK FACTOR; SEASONAL VARIATION; SEX DIFFERENCE; SMOKING; SYMPTOM; TREATMENT DURATION;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; RISK; SEASONS; TREATMENT OUTCOME;

EID: 84855391731     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00194610     Document Type: Article

References (42)

1. Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004; 59: 387-395. (Pubitemid 38624744)
2. Donaldson GC, Wedzicha JA. COPD exacerbations. 1. Epidemiology. Thorax 2006; 61: 164-168.
3. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 188-207. (Pubitemid 43092683)
4. Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006; 27: 397-412. (Pubitemid 43180921)
5. Seemungal TAR, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
6. Soler-Cataluna JJ, Martinez-Garcia MA, Sanchez PR, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931. (Pubitemid 41598207)
7. Garcia-Aymerich J, Farrero E, Felez MA, et al. Risk factors for readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100-105. (Pubitemid 36182995)
8. Kessler R, Faller M, Fourgaut G, et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 158-164. (Pubitemid 29036519)
9. Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1608-1613. (Pubitemid 30329036)
10. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-1138.
11. Johnston NW. The similarities and differences of epidemic cycles of chronic obstructive pulmonary disease and asthma exacerbations. Proc Am Thorac Soc 2007; 4: 591-596. (Pubitemid 350291619)
12. Bryden C, Bird W, Titley HA, et al. Stratification of COPD patients by previous admission for targeting of preventative care. Respir Med 2009; 103: 558-565.
13. de la Iglesia Martinez F, Pellicer Vazquez C, Ramos Polledo V, et al. Chronic obstructive pulmonary disease and the seasons of the year. Arch Bronconeumol 2000; 36: 84-89. (Pubitemid 30128792)
14. Donaldson GC, Seemungal T, Jeffries DJ, et al. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 844-849. (Pubitemid 29234789)
15. Dowell SF, Ho MS. Seasonality of infectious diseases and severe acute respiratory syndrome - what we know can't hurt us. Lancet Infect Dis 2004; 4: 704-708. (Pubitemid 39452524)
16. Wilkinson P, Patenden S, Armstrong B, et al. Vulnerability to winter mortality in elderly people in Britain: population based study. BMJ 2004; 329: 647-650.
17. Bryden C, Bird W, Halpin DM, et al. Seasonality in chronic obstructive pulmonary disease emergency admissions to hospital, and predictability using surveillance for influenza-like illness. Thorax 2006; 61: Suppl. 2, S079.
18. Shek LP, Lee BW. Epidemiology and seasonality of respiratory tract infections in the tropics. Paediatr Respir Rev 2003; 4: 105-111.
19. Chew FT, Dorasingham S, Ling AE, et al. Seasonal trends of viral respiratory tract infections in the tropics. Epidemiol Infect 1998; 121: 121-128. (Pubitemid 28423337)
20. Dowell SF. Seasonal variation in host susceptibility and cycles of certain infectious diseases. Emerging Infect Dis 2001; 7: 369-374.
21. Calverley PMA, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-789. (Pubitemid 46294610)
22. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows: Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
23. Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008; 31: 416-468.
24. Eccles R. An explanation for the seasonality of acute upper respiratory tract viral infections. Acta Otolaryngol 2002; 122: 183-191. (Pubitemid 34270825)
25. Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. The Eurowinter Group. Lancet 1997; 349: 1341-1346.
26. UK Met Office. Healthy Outlook1 COPD forecast alert service. www.metoffice.gov.uk/health/public/copd Date last updated: June 14, 2011. Date last accessed: October 21, 2011.
27. Hajat S, Kovats RS, Lachowycz K. Heat-related and cold-related deaths in England and Wales: who is at risk? Occup Environ Med 2007; 64: 93-100.
28. Goodwin J, Taylor RS, Pearce VR, et al. Seasonal cold, excursional behaviour, clothing protection and physical activity in young and old subjects. Int J Circumpolar Health 2000; 59: 195-203.
29. Ko FWS, Tam W, Wong TW, et al. Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong. Thorax 2007; 62: 780-785.
30. Yap FH, Ho PL, Lam KF, et al. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol 2004; 73: 617-623. (Pubitemid 38857215)
31. Viboud C, Alonso WJ, Simonsen L. Influenza in tropical regions. PLoS Med 2006; 3: e89.
32. Wallace J, Nair P, Kanaroglou P. Atmospheric remote sensing to detect effects of temperature inversions on sputum cell counts in airway diseases. Envir Res 2010; 110: 624-32.
33. Bi P, Wang J, Hiller JE. Weather: driving force behind the transmission of severe acute respiratory syndrome in China? Int Med J 2007; 37: 550-554. (Pubitemid 47084169)
34. Dewan NA, Rafique S, Kanwar B, et al. Acute exacerbation of COPD. Factors associated with poor treatment outcome. Chest 2000; 117: 662-671. (Pubitemid 30152203)
35. Dales RE, Mehdizadeh A, Aaron SD, et al. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J 2006; 28: 319-322. (Pubitemid 44914230)
36. Celli B, Vestbo J, Jenkins CR, et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease: the TORCH experience. Am J Respir Crit Care Med 2011; 183: 317-322.
37. Watson L, Schouten JP, Löfdahl C-G, et al. Predictors of COPD symptoms: does the sex of the patient matter? Eur Respir J 2006; 28: 311-318. (Pubitemid 44914229)
38. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61: 772-778. (Pubitemid 44369401)
39. Coote K, Nicholls A, Atherton HC, et al. Mucociliary clearance is enhanced in rat models of cigarette smoke and lipopolysaccharide-induced lung disease. Exp Lung Res 2004; 30: 59-71. (Pubitemid 38117526)
40. Lalloo UG. The cough reflex and the "healthy smoker". Chest 2003; 123: 660-662.
41. Wilkinson P, Pattenden S, Armstrong A, et al. Vulnerability to winter mortality in elderly people in Britain: population based study. BMJ 2004; 329: 647.
42. McGarvey LP, John M, Anderson JA, et al. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62: 411-415. (Pubitemid 46698390)